Convergent Dental recently completed a $40 million series C funding round led by Arboretum Ventures, with participation from existing investors, including Long River Ventures and the Gund Foundation.
The company said it plans to launch new products and increase market penetration. Its current products include Solea, an all-tissue laser that enables cavities to be treated without anesthesia and soft-tissue surgeries to be completed with little to no anesthesia, bleeding, or sutures.
Convergent also recently launched Solea Sleep, a nonsurgical treatment for snoring that works by tightening tissue in the soft palate in a five-minute treatment, the company said.
